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Abstract 
 
Purpose: The aim of this paper is to explore, through exploratory qualitative research, 
how perceptions of involvement and risk, for female consumers, influences their 
information search and product evaluation decision-making for Over-the-Counter 
(OTC) painkillers. 
 
Methodology: In-depth interviews were conducted amongst twenty-five female OTC 
painkiller purchasers from one pharmacy. Females are more engaged with and have a 
greater likelihood to use OTC medication. Despite the benefits of applying qualitative 
approaches when researching self-medication, there are few self-care qualitative 
studies. 
 
Findings: Despite the greater availability and awareness of OTC medicines, the 
purchasing process is still underpinned by inherent risk. Alongside base levels of 
involvement, painkillers had situational importance with there being unease as to the 
risk involved. Consumers felt uncertainty as to the worth of their knowledge and this 
was compounded by a lack of informational clarity. Finally, the risk of side-effects 
and the relative importance of subjective beliefs often took precedence during 
evaluation. 
 
Research limitations/implications: Information needs to be made more accessible, 
whilst there is scope to capitalise upon family history as interpersonal sources were 
deemed to be empathetic. As the study was conducted once in a ‘local’ setting, the 
time span and level of interactivity could be extended by studying consumers ‘lived 
experiences’. Triangulated research amongst related parties, such as pharmacists, 
could build on this exploratory study. 
 
Originality/value: OTC medicine sales have grown with self-medicating consumers 
purchasing painkillers the most frequently. Previous research has stemmed from 
medical sociology, pharmacy practice and public policy, and there is a lack of 
contemporary (UK) consumer behaviour research on OTC painkiller purchasing. 
 
Keywords: painkiller purchasing, involvement, risk, information search, evaluation 
 
Article type: Research paper 
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Introduction 
Pain relieving analgesics are the largest sector in the growing Over-the-Counter 
(OTC) pharmacy market (Keynote, 2004; PAGB, 2005a) with 90% of UK consumers 
using painkillers annually (PAGB, 2005b). Consumer awareness of self-care issues 
has been associated with the importance of OTC availability (PAGB, 1997), both of 
which are reflected in increasing product choice (PAGB, 2005c). Perhaps 
surprisingly, in view of the scale and importance of OTC medication purchasing, 
Ward & Tully (1998) noted a lack of research on consumer views of OTC medication. 
Although OTC medication has been researched in medical sociology, pharmacy 
practice and public policy, there is a lack of contemporary (UK) consumer behaviour 
research on OTC painkiller purchasing. In distinguishing between prescribed 
medicines and OTCs, the terms patient and consumer are associated, respectively, 
with each classification. The emphasis on OTC purchasers as consumers is a function 
of, and reaction to, the involvement associated with self-care. Although consumers 
may make a greater input into the decision-making process compared to patients, 
OTC purchasing is still associated with risk. It is the continued existence of this risk 
that distinguishes the decision-making process for OTCs notwithstanding that it is not 
the only purchasing situation where one has to be mindful of such considerations. 
 
The aim of this paper is to explore, through exploratory qualitative research, how 
perceptions of involvement and risk, for female consumers, influences their 
information search and product evaluation decision-making for OTC painkillers. 
Thereafter, a series of objectives sought to uncover the following phenomena: 
 
To explore involvement and risk perceptions associated with OTC painkillers; 
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To probe the types and usage of sources accessed during the stage of information 
search; 
To identify the relevance of different product evaluation dimensions. 
 
OTC medicine sales have grown following their re-classification from prescription 
drugs. As well as these changing regulations, self-care information is more available 
(Westerlund et al., 2001). Concerns over healthcare have resulted in greater consumer 
engagement and knowledge (Chewning & Sleath, 1996; Gould et al., 1997; Prayle & 
Brazier, 1998). However, the inherent risk of medication together with the role of 
information in reducing risk perceptions exists alongside consumer empowerment 
(Bissell et al., 2001). At the same juncture, the evolution of OTC positioning from a 
medicine to a readily available brand necessitates an exploration of where they lie in 
the low to high involvement continuum. 
 
Within consumer decision-making, the alternatives identified during information 
search provide the basis for subsequent evaluation. Consequently, there is logic in 
examining these together. Underlying these are the related concepts of involvement 
and risk. Although risk has been considered as an antecedent to involvement (Chaffee 
& McLeod, 1973), a consumer’s risk conceptualisation has been viewed as an 
inherent part of involvement (Laurent & Kapferer, 1985; Mitchell, 1999). Instead of 
being sequential, they coalesce. Risk is significant if consumers seek to avoid 
inappropriate choices instead of maximising their purchase’s utility (Mitchell, 1999). 
 
OTC purchasing occurs within a dynamic marketplace and these contextual 
developments have influenced the sector’s evolution. First, regulators and suppliers 
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have shifted cost onto consumers (Creyer et al., 2001; Keynote, 2004). Drug life 
cycles can be extended and pre-existing brand equity capitalised upon through OTC 
status (Blenkinsopp & Bradley, 1996; Keynote, 2002). Since generic drugs can erode 
the patent holder’s market share, trading conditions have intensified. Secondly, 
segmentation has focused upon occasion-based differentiation with 15% of purchasers 
being defined as heavy users that take painkillers at least twice a week (Keynote, 
2000). Whilst variant choice has been one outcome of competitive intensity, another 
influence is that OTCs have accounted for a substantial portion of pharmaceutical 
sector growth (Schmidt & Pioch, 2004). 
 
Thirdly, consumer benefits associated with cost and convenience gives self-
medication greater utility (Oster et al., 1990; Hughes et al., 2001; Sleath et al., 2001). 
These trends exemplify heathcare’s shifting emphasis from that of patient to customer 
(Sargeant, 1999). Popovich et al. (1992) predicted the emergence of self-care with 
Alberts et al. (1998) identifying an association between it and consumer 
empowerment. Marketing Week (2005) showed overwhelming consumer support 
(96%) for self-medication and empowerment. Painkillers are the most widely 
purchased OTC medicine with approximately ninety variants (CMP, 2002). Most 
adults experience ailments regularly with a substantial minority treating these with 
OTCs (Knapp & Knapp, 1972; Bissell et al., 2001). Increases in painkiller usage have 
been attributed to lifestyle shifts militating against time being ‘lost’, thus creating a 
demand for immediate relief (Vuckovic & Nichter, 1997). Finally, retail pharmacists 
have evolved from being simply dispensers, with an operational focus, to having a 
more holistic management role that utilises their professional advice (NHS, 2000). 
 5
This paper seeks to address a number of inter-related theoretical, methodological and 
contextual gaps in the current literature. As noted, research on OTC medication has 
been concentrated in other disciplines, notably medical sociology, pharmacy practice 
and public policy. These disciplines lack a shared literature with consumer decision-
making behaviour. Although consumer perceptions (Wazaify et al., 1995) and usage 
patterns (Sinclair et al., 2000) of OTC products have been researched, they were not 
conceptually grounded and did not look through the disciplinary lens of consumer 
behaviour.  
 
Theoretically, this paper is situated within the domain of consumer involvement and 
risk. In developing this literature, albeit within a specific product category, this paper 
seeks to integrate involvement and risk, the relationship between which has been 
examined by Venkatraman (1989), with that of information search and product 
evaluation. Related OTC research has looked either at selected phenomena, such as 
the interplay between risk and information (Berry et al., 2004), or, alternatively, at 
information routed through one source or else directed to a particular demographic 
group. With regard to the former, Nichol et al. (1992) focused on pharmacist 
consultations with Sleath et al. (2001) centring on doctors, whilst Minkus-McKenna 
(2006) has explored OTC communications amongst older consumers. In view of the 
role that better information could play in facilitating consumers self-care behaviour 
(Department of Health, 2005), there is value in qualitatively uncovering this decision-
making process holistically. Grounding this paper within consumer behaviour not 
only helps to address the call by Ward & Tully (1998) for greater attention to be 
devoted to consumers views of OTC medication, but it also complements Lyon 
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(2001) who explored the strategic position of the OTC market from a managerial 
perspective. 
 
Methodologically, the qualitative focus helped to address a lacuna in how this subject 
area has been investigated. Chapple & Rogers’s (1999) observation that there were 
few self-care qualitative studies reiterated Vuckovic & Nichter (1997) in their view 
that the research base - where the ‘whats’ have been the focus rather than exploring 
the ‘whys’ - has been overly descriptive. Dill et al. (1995) noted that the 
preponderance of quantitative studies limited one’s ability to derive rich insights from 
the research subjects. In short, there was a rationale for this paper to employ an 
explicitly qualitative focus. Irrespective of the approach, the focus on female 
consumers - as a research subject - could be rationalised on several bases. Not only do 
women discuss their health more candidly than men (Ganther et al., 2001), but they 
are also more likely to use medication (Dean, 1989). They are also more likely to 
report an ailment (Anson et al., 1993) and they are more involved in purchasing 
medicine than men (Vuckovic, 1999). Instead of exploring the entire OTC market, 
there was a rationale for focusing on painkillers. In addition to its market dynamics 
and gender significance, the process of researching painkillers can be less 
embarrassing.  
 
Contextually, the dynamic and evolving nature of the UK’s OTC market warrants 
contemporary research given that a number of related articles could now be deemed to 
be historical. Gore et al. (1994) assessed, quantitatively, the relationship between 
involvement and information for OTC purchasing, although this is now relatively 
dated and is American, rather than British, in origin. British research (Rodway, 1995) 
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suggested that the market was characterised by a lack of consumer understanding. As 
the OTC market has become more fully embedded, there is a rationale for exploring 
the nature of the decision-making process. 
 
This paper is divided into four sections. In the first section, the relevance of 
involvement and risk for information search together with product evaluation, as 
applied to OTC purchasing, is established. Thereafter, the qualitative research 
methodology is detailed. Thirdly, the qualitative analysis explores the phenomena 
underpinning involvement and risk of OTC purchasing together with the influence on 
information search and product evaluation decision-making. Finally, the theoretical 
conclusion highlights the importance of involvement and risk in this context, whilst 
pointing to ways in which this evolving sector’s challenges can be better addressed. 
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Involvement and Risk: Information Search and Product Evaluation 
Involvement and Risk 
Changes in OTC purchasing have been accompanied by greater consumer 
involvement. Alongside this evolution, though, medication purchasing still involves 
risk with Cox & Rich (1964) defining risk as the consumer’s willingness to increase 
their vulnerability or likelihood to potential failure when purchasing. Risk influences 
the extent and nature of information search that occurs (Urbany et al., 1989) with 
Bissell et al. (2001) suggesting that information can ease the risk perceptions 
associated with medication. 
 
Purchasing is influenced by how information searching filters through to evaluation. 
In order to avoid inappropriate choices that pose greater risk, a consumer may place 
less prioritisation on maximising their purchase’s utility (Mitchell, 1999). 
Consequently, risk minimisation may be given precedence over brand optimisation. 
Instead of involvement and risk existing discretely, Mitchell (1999) argues that they 
are integral whilst Laurent & Kapferer (1985) suggested that risk is embedded within 
involvement. In addition, Laaksonen (1994) suggested that risk influenced 
involvement. Involvement and risk signify the product’s ‘importance’ and salience 
(Bloch & Richins, 1983).  
 
Involvement has been defined as ‘the arousal, interest and drive evoked by a product 
class’ (Dholakia, 2000); in turn, this reflects the product’s relevance (Zaichkowsky, 
1985). Involvement results in search and evaluation (Antil, 1984) with these activities 
being ‘measured’ along a spectrum from high to low involvement. Highly involved 
consumers have a greater propensity to be engaged in more extensive evaluative 
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processes (Zaichkowsky, 1985). Since OTCs have a low monetary value and are 
habitually purchased, low involvement is more likely (Rodway, 1995). In a low 
involvement scenario, an awareness, trial and repeat purchase (ATR) model 
(Ehrenberg & Goodhart, 1980) indicates simple rather than extensive decision-
making. Active information seeking may be absent if consumers are passive and 
satisfied. More specifically, Brades (1990) outlined a ‘pain, medication, relief’ model 
for consumers that consider painkillers to be of low interest. 
 
Generic categorisations of perceived risk (Jacoby & Kaplan, 1972; Dholakia, 2000) 
exist alongside specific self-treatment risks (Charupatanapong, 1994). First, there is 
financial risk. With the exception of heavy users, OTC consumers are unlikely to 
experience significant financial risk. Low financial risk is associated with a 
correspondingly low level of social risk with the latter cited as the least influential for 
OTC medication. Therefore, there are parallels with typical low involvement 
purchases. In contrast, there are identifiable psychological risks with the potentially 
harmful effects of medication causing unease. In this respect, OTC consumption 
corresponds to a high involvement context. Temporal and psychological risks are 
allied. Since a determination of risk is the immediacy and duration of relief, the time 
risk is influential in stimulating product use. Finally, there are physical risks: 
performance and safety. Performance relates to the degree of effectiveness and 
efficacy, whilst safety centres on the possible dangers of misapplication. 
 
Information Search 
When purchasing OTC painkillers, a consumer’s information originates from their 
existing knowledge or experience (internal sources) and from a variety of external 
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sources: pharmacists, interpersonal communication, advertising and the media 
(Strutton & Pelton, 1992). Although some consumers rely on their own experience 
(Morrow et al., 1993), pharmacists may occupy an important role in providing not 
only advice (Bissell et al., 2000) but also a level of information that is sufficient for 
product use (Tully et al., 1997). 
 
Pharmacists can be pivotal in ensuring consumer safety together with product efficacy 
(Prayle & Brazier, 1998). Nichol et al. (1992) demonstrated that a significant minority 
of consumers, following the pharmacist’s intervention, purchased a different OTC 
than intended. Pharmacists have simultaneous roles; subjectively, they have 
commercial interests in selling and more objectively, they provide impartial advice. 
Whilst conflict may exist between commercial roles and professional duties (Pioch & 
Schmidt, 2004), Blenkinsopp & Bradley (1996) argued that these could be reconciled. 
 
Whilst pharmacists influence OTC decision-making at the point of purchase, Rodway 
(1995) noted that consumers often deem interpersonal communication from family, 
friends and colleagues to be significant on account of their own relative lack of 
engagement with this category. For consumers whose superficial knowledge is reliant 
on emotive appeals, interpersonal communication can be instrumental as a substitute 
if it is deemed trustworthy. 
 
Thirdly, brand choice can be determined by packaging and retailer information. This 
can ameliorate for a consumer’s inability to interpret information where a plethora of 
brands exists (Kavanoor et al., 1997). Brands with identikit perceptions can be 
difficult to distinguish if consumers lack specialist knowledge. Consumers may fail to 
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optimise their brand choice due to variety and ambiguity (Mitchell & Papavassiliou, 
1999). In particular, the elderly may be disadvantaged by poor leaflet clarity 
(Wogalter & Dietrich, 1995). This affects information assimilation and transparency. 
 
Finally, consumers acquire information through media sources (Gray et al., 1998). 
Direct advertising impacts upon symptom awareness and pertinent treatments (Creyer 
et al., 2001) with comparative adverts being the most persuasive (Kavanoor et al., 
1997). Web information allows consumers to acquire medication knowledge through 
dialogue with health professionals (Cohen et al., 2001). Manufacturers have 
responded to this growing consumer advocacy by publishing advertorial web pages 
that fulfil dual roles by fusing information with advertising (Spain et al., 2001). 
 
Product Evaluation 
Sequentially, product evaluation follows information search. There are a number of 
evaluative influences: product qualities and attributes, a consumer’s loyalty and 
knowledge, demographic factors and finally, temporal pressures induced by symptom 
immediacy. 
 
When viewed subjectively, the majority of consumers perceive painkillers to be safe 
and risk free (Bissell et al., 2001) with the promotional language used by 
manufacturers reinforcing this through reassuring associations. Price differentials 
exist with the cheapest being a fraction of the most expensive. This affects consumers 
with limited finances or heavy usage. Brand proliferation has resulted in segments 
being targeted with different positioning strategies. Altering the formulation is a 
differentiating tool that can warrant a price premium on account of supposed 
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superiority. Despite it being difficult to objectively evaluate any benefits, these 
formulations appeal to consumers (Hardcastle, 2001). Since this market is 
characterised by ingrained brand loyalty (PAGB, 2005c) together with entrenched 
buying patterns (Rodway, 1995), there is a rationale for this form of marketing. 
 
Physical characteristics of OTC medication can make them difficult to consume and 
the ease of consumption is a consideration. Easier oral administration has been used 
as a differentiating tool (Hardcastle, 2001). Since these qualities are transparent, 
consumers can be willing to pay the premium. Perceived or assumed strength relative 
to other OTCs is a criterion, although the reclassification in status of many drugs from 
prescription to OTC has not been accompanied by a corresponding realignment of 
perceptions. Compared to medications that have only enjoyed OTC status, the 
perceptions for reclassified medications are more powerful. Impressions of strength 
can be conveyed through manufacturers deploying terms such as ‘combat’ or ‘attack’ 
on the packaging and promotion (Rodway, 1995). If consumer knowledge of product 
attributes is scant, their evaluation may be more emotional or ‘irrational’.  
 
Demographic factors have an impact on OTC evaluation (Schufeldt et al., 1998). 
Despite some OTCs being deemed as ineffective or inappropriate (Nichol et al., 
1992), a more adept consumer can deviate from the pharmacist’s advice. Older 
segments have greater faith in doctors and are less sceptical towards healthcare 
(Ganther et al., 2001). Elderly consumers use OTCs in preference to prescriptions and 
they are more engaged in purchase deliberations than their younger counterparts 
(Sansgiry & Cady, 1996). Finally, temporal factors centring on the immediate 
symptoms are significant. Since the nature and immediacy may preclude rational 
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thought, the consumer is spurred on by emotional and physiological triggers (Lees, 
1995). 
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Methodology 
Exploratory qualitative research was conducted amongst female OTC painkiller 
purchasers in an independently owned pharmacy outlet rather than a multiple. Bissell 
et al. (2001) contended that qualitative research encourages consumers to interpret 
and analyse their reasoning for self-medication. In designing the research, an 
interpretative approach applied in a particular social context (VanMaanen, 1979), 
which was framed and focused around a ‘unit of one’ (Wolcott, 1990), sought to 
discover phenomena through an in-depth exploration of what was happening (Robson, 
1993).  
 
Structurally, a hybrid of deductive and inductive approaches was employed. 
Notwithstanding the exploratory focus, which places stress on generating new insights 
(Kent, 1999) rather than testing existing concepts, a degree of deductive structure was 
applied. As existing concepts were used as an initial basis and perspective (Cresswell, 
1993) that provided an underpinning (Fetterman, 1989), the study was not situated 
within a theoretical vacuum. Prior theory guided the research in that deductive pre-
specification was blended with inductive reasoning rather than the process being 
dichotomous. Induction allowed for new or unsuspected phenomena (Miles & 
Huberman, 1984), which can be interpreted as themes, to emerge (Flick, 1998) and 
for the analysis to uncover these (O’Leary, 2004). 
 
There were two sampling stages. Criterion sampling (Patton, 1990) was used with 
female purchasers of OTC painkillers. Thereafter, purposive sampling that entailed 
the deliberate selection of research subjects (Mason, 1996), together with convenience 
sampling, was used. Respondents were screened on the basis of staff asking female 
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customers, who were purchasing that product category, for their participation in an in-
depth interview. This had several benefits: their perceptions would help to illuminate 
the process under study (Denzin & Lincoln, 1994); these phenomena would be nested 
and situated in a distinct location, and, finally, there was a degree of ‘local 
groundedness’ (Silverman, 1993). Situating the interviews in close physical proximity 
(Rossman & Rallis, 1998) and time span to the specific context helped to better 
ensure validity, as the depth and richness that was derived contributed to the data’s 
‘goodness’ (Sykes, 1990).  
 
Collection of the data involved twenty-five in-depth interviews conducted in a 
separate room in the pharmacy where co-operation had been secured. As the granting 
of interviews by respondents was ultimately dependent on them volunteering, 
purposive techniques were accompanied with convenience sampling (DePoy & Gitlin, 
1994). 
 
All interviewees were customers of that pharmacy, the choice of which was 
influenced by its profile of OTC and prescription customers. In contrast, pharmacies 
dependent upon prescription handling were a less viable target. Profile information on 
the interviewees can be found in Table I. Semi-structured in-depth interviews offered 
a degree of latitude (May, 1997) that allowed for perceptions to be generated (Miller, 
1997) of that individual’s perspective (Fontana & Frey, 1994). Applying a mixed 
process of deduction and induction tallied with the use of in-depth interviews 
(O’Leary, 2004) with this method lying equidistant between a purely positivistic as 
opposed to a wholly interpretative approach (Carson et al., 2001). As such, the 
division of the interviews into three sections reconciled inductive flexibility with the 
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need for being methodical in a deductive manner. First, involvement and risk 
perceptions were explored. Secondly, the types and usage of information search were 
probed and, finally, the relevance of different evaluation dimensions was sought.  
 
Take in Table I 
 
Analysis of the interviews was achieved through, firstly, transcribing the tape-
recordings. The data was analysed in accordance with the components of Miles & 
Huberman (1994): data reduction, data display, and drawing and verifying 
conclusions. Applying a qualitative software package (WinMax) allowed the data to 
be, firstly, coded. As the initial stage in qualitative analysis (Bryman, 2001), which 
attaches meaning to the pieces of raw data, the resultant conceptualisation (Strauss, 
1988) allowed for the subsequent development of categories. Once the material had 
been reduced after having been coded, organised into themes and then categorised, the 
process of drawing conclusions was undertaken.  
 
Utilising a hybrid of deductive and inductive approaches required a degree of 
comparison with previous work. Consequently, the consistencies drawn out from the 
categories were used in a comparative manner against relevant theory (Gray, 2004) 
with this tallying with one of the tactics advocated as part of the Miles & Huberman 
framework. However, applying the latter authors stress on making comparisons 
existed alongside a concurrent need for the material to be interpreted in relation to the 
contextual parameters (Dunne et al., 2005). By doing so, deductive logic together 
with inductive reasoning was better blended with this allowing for both parallels and 
contrasts. 
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Displaying the data allowed for consumer perceptions to be explored and unpacked. A 
number of quotes were incorporated which enabled the phenomena in question to be 
displayed as a ‘picture’ (Buchanan, 1992) that illuminated the research by adding 
‘colour’ (Green & Thorogood, 2004). 
 
Employing a partially inductive approach lessened the need for generalisation as 
greater significance was attached to the understanding of what was occurring 
contextually (Saunders et al., 2000). Through being attuned and sensitive to the 
contextual nuances, the emergent data revealed complexity and detail, and, as such, its 
validity was enhanced through the accurate representation of the social phenomena 
which it was depicting (Hammersley, 1990). Since the research was contextually 
specific, in terms of how a product category was perceived by a particular gender 
group, the extent to which the phenomena can be generalised are limited.  
 
Despite the contextual specificity, there was a rationale for studying female 
consumers through interpretative research around a bounded purchasing situation of 
one gender group. In their medicine purchasing and usage they are deemed to be more 
proactive than men (Vuckovic, 1999). Deciding whether to apply focus groups or, 
alternatively, in-depth interviews was influenced by a number of considerations. 
Independently of any gender related factors, the scheduling of focus groups can be 
problematic. In relation to gender, the advantages that focus groups afford compared 
to in-depth interviews, in the sense of the group interaction and insight generation, 
could be counteracted with several downsides. Notwithstanding that painkiller 
discussion is less sensitive than for other medications, the lack of privacy in a focus 
group might result in some insights being lost. In short, the research subjects would be 
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more forthcoming in an in-depth interview situation that capitalised on their insights 
in a more discrete manner. 
 
One limitation of focusing on females was to limit the generalising of these findings 
to men. In common with previous research, such as Vuckovic (1999) and Sinclair et 
al. (2000), the female consumers in this study were similarly proactive with this being 
in a context of females having to juggle multiple roles. Although the focus was solely 
on the respondents, rather than on their broader purchasing and subsequent usage in 
relation to other parties, the probing and inquisitive nature of qualitative research 
means that one has to be mindful of this more encompassing role that they may 
perform compared to men.  Due to the complexity and subjectivity of pain from a 
gender perspective (Melton, 2002), the ability to simply extrapolate these findings to a 
male decision-making environment may be problematic. Adapting the findings and 
implications for male consumers would need to accommodate their more disengaged 
behaviour and, consequently, caution needs to be exercised in merely transferring the 
phenomena that relate to generally more proactive female consumers. 
 
Irrespective of the paper’s gender focus, the ability to apply the findings elsewhere, in 
the sense of progressing from a distinct case to a whole population (Silverman, 2000), 
may be problematic as it is difficult to ‘freeze’ or contain a particular setting in order 
to allow replication (LeCompte & Goetz, 1982). Even if replication is sought, merely 
applying principles of generalisation universally can be flawed as local conditions can 
militate against any ability to generalise (Lincoln & Guba, 1985). More specifically, it 
has been suggested that in-depth interviews, as a chosen research method, cannot be 
reconciled with generalisation (Carson et al., 2001). 
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Despite the high degree of local grounding lending the research validity, with this 
being a function of the immediacy of the interviews relative to the purchasing context, 
a number of research limitations were inherent. Compared to a triangulated approach 
that uncovers a true ‘fix’ on a situation by using multiple sources of data (Denzin, 
1970), which allows for a degree of corroboration (Mason, 1996), the uni-dimensional 
nature of the in-depth interviews was a limitation. There are a number of research 
directions that could attend to this by illuminating the subject from multiple 
perspectives. This could be achieved by researching the same subjects differently and 
more extensively or, alternatively or in addition to, by researching the input of related 
parties, such as pharmacists. Any subsequent research would seek to substantiate and 
confirm the exploratory work.  
 
Notwithstanding the use of in-depth interviews in a ‘local’ setting, a rationale exists 
for extending the scope of the interview process in terms of the time span and the 
level of interactivity. Phenomenological research, in the form of studying the 
‘lifeworld’ experience of individuals (Tesch, 1994), permits a fuller understanding of 
their ‘lived experiences’ (Moustakas, 1994) with the investigation being able to glean 
this over an extended time period rather than on one occasion. 
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Analysis 
The first part of the analysis explores involvement and risk when purchasing 
painkillers. Table II summarises the qualitative phenomena from the interviews 
together with implications. Thereafter, the sections are structured according to the 
literature review: information search and product evaluation. Tables III and IV 
summarise, respectively, the significance of internal and external information sources, 
and the evaluative dimensions, as revealed by interviewees. 
 
Involvement and Risk 
Overall, painkillers were purchased in order to ensure a continual supply. Younger 
interviewees, in particular, maintained supplies to alleviate the onset of pain. 
Anticipated pain was addressed through having a continual supply. Significantly, light 
users and those with heavier usage patterns had an equal propensity to stock 
painkillers. Consequently, there was a base level of involvement with all the 
interviewees noting that they had a stock of painkillers at home as well as carrying a 
supply outwith their house. Ensuring an available supply denoted anticipated 
purchasing patterns with appropriate contingencies being made for sudden pain: 
 
‘When I take them, yes. When I buy them…Maybe not then. I don’t think so much 
about taking them…I just want to have them in the house. There is a difference, see?’ 
(interviewee 19). 
 
Whilst having a continual supply was important, these base levels of involvement did 
not equate into interest. Ingrained on-going interest was of minor importance. 
Crucially, painkillers did not exhibit low involvement characteristics. Rather, the pain 
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together with medication was highly situational and transient. Involvement receded in 
parallel with symptom relief with base levels of interest being evoked by temporal 
conditions. Any emerging involvement in painkillers corresponded to the product’s 
immediate relevance and urgency engendering strong emotions: 
 
‘Generally I don’t think or care about painkillers unless I have a headache, then I’m 
like, oh my god there’s no painkillers here, what can I do? Otherwise, I don’t really 
think about them, only when I’m in pain’ (interviewee 2). 
 
As previously outlined, the coalescence of risk and involvement are signifiers of 
product ‘importance’. Perceptions of risk and actual behaviour were highly 
situational. Risk perceptions were influenced by the continuity of use engendering 
greater reassurance and lessening safety concerns. However, there were feelings that 
manufacturers were abdicating their onus of responsibility. One manifestation of this 
transference of responsibility onto consumers was the unease generated by side-
effects. Ironically, perceived risk and uncertainty was exacerbated by greater 
transparency: 
 
‘Sometimes they tell you the great things that the drug does and then list the side-
effects. And you’re like oh my gosh. Then you have this decision to make and that’s 
the scary bit. You’re like, shall I take it? You say to yourself, how am I supposed to 
know if these things are going to happen or not? They push the responsibility to the 
consumer and advise you on the things that might happen’ (interviewee 8). 
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Despite this information being objective rather than subjective, there were finite limits 
to consumer assimilation. The inability to ascertain the likelihood of side-effects 
created dissonance. Two compensatory mechanisms were used. First, emotive 
reasoning took precedence if it was difficult to interpret objective information. 
Significantly, knowledgeable interviewees were as equally reliant on this as less 
informed consumers, which differs from previous research (Rodway, 1995). 
Secondly, obtaining advice from multiple sources ameliorated this increased risk. 
 
Interviewees with more complex medication patterns applied different painkillers 
according to symptom. However, complexity was not equated with greater 
knowledge. Interviewees with rudimentary knowledge were more rigid in their 
perceptions of what variant suited particular symptoms: 
 
‘I have developed in my mind, aspirin for long-term relief, but slowly affecting your 
system, and paracetamol is fast acting, but for short term, and Mezulid (a 
prescription painkiller) is for severe pain. It’s how I’ve categorised them in my mind 
and it's how I use them’ (interviewee 3). 
 
In contrast, knowledgeable consumers used the same painkiller irrespective of 
symptom, which suggests a willingness to use ‘substitutes’. Those with less extensive 
knowledge viewed this as an improvisation. Consequently, knowledgeable consumers 
were more sceptical of, and resistant to, the idea of real differences existing between 
painkillers. Greater knowledge was equated with simpler medication patterns that 
used these ‘substitutes’ and, concomitantly, a highly involved consumer with a more 
complex medication pattern did not necessarily possess the greatest knowledge. 
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Take in Table II 
 
Information Search 
Internalised sources were significant. This encapsulated painkiller cognisance, but 
also prior usage. Recounting previous consumption had a significant impact with 
particular painkillers being preferred due to the feeling of family tradition that it 
evoked and conjured up: 
 
‘My mother bought this painkiller when I was sick as a child, so I feel close to them, 
very used to them. And I will not stop using them probably because they are effective. 
It’s a family thing. My mother was hunting me around the house with the painkillers 
saying ‘do you feel bad’ and then giving them to me. That was nice’ (interviewee 3). 
 
However, there were doubts as to whether their knowledge was meaningful. 
Consequently, this lack of understanding exacerbated the problems of consumers 
being exposed to risk (Sansgiry & Cady, 1996). Guilt was experienced if information 
could not be comprehended, thus suggesting that in their quest to be more informed 
they felt thwarted. Concomitantly, though, they were not prepared to invest effort. 
Facilitating the process of acquiring information could ease this. 
 
Externalised information searching was initiated by symptom onset or brand 
unavailability. Differences were noted between the importance ascribed to particular 
sources, as opposed to the level of reference attached to them. Despite GP or 
pharmacist advice being seen as important, these sentiments did not always translate 
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into experience. Therefore, a disparity appeared between ‘what you should do’, as 
opposed to ‘what I really do’. However, trust was vested in pharmacists: 
 
‘If I have a good impression about the person behind the counter, then I will believe it 
(their advice)’ (interviewee 15). 
 
Pioch & Schmidt (2004) considered these to be instrumental qualities. One 
manifestation was that a select number of pharmacists, who had established credibility 
and rapport, were consulted. However, there were caveats since recommending a 
substitute brand was felt to constitute an invasion of privacy. However, this dubiety 
was not attributed to a conflict of interest or a lack of impartiality as suggested by 
Prayle & Brazier (1998). Concerns centred on expertise and competence, which 
suggests that pharmacists need to surmount perceptual barriers. Although older 
interviewees were self-assured in managing their symptoms, there were differing 
patterns from Sansgiry & Cady (1996) in that they did not request more advice from 
pharmacists than younger segments. 
 
GP advice was less significant than that of pharmacists with the latter being seen as 
more trustworthy. This echoes Williams & Calnan’s (1996) discussion of consumers 
questioning of doctors, although Bradley et al. (1998) pointed towards more 
favourable attitudes. In interpreting GP advice, the need for a minimum level of 
knowledge was an impediment. Less proficient consumers were disadvantaged and 
this was compounded by patronising advice. Consequently, there was a perception 
that decisions were foisted upon consumers rather than the process incorporating 
them: 
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‘You must have a certain..what shall I call it..level of knowledge before you are able 
to make any decision. That is why I don’t think I have the information that I need. At 
the end of the day, the doctor makes the decision. But he does not make me feel like I 
am part of that decision..just a patient to be talked down to’ (interviewee 19). 
 
These perceptual barriers limited the ability of consumers to apply advice. This differs 
from more proactive approaches to healthcare (Sargeant, 1999). Interviewees who 
actively sought information from their doctor were more involved in their health. 
 
Interpersonal communication from family and friends was crucial due to its credibility 
and empathy. In contrast to other external sources, product packaging was viewed as 
supplementary rather than pivotal. Information was felt to be regulatory-driven rather 
than being disseminated for the consumer’s benefit; consequently, it was not 
transparent and did not perform the role of ‘solution to problem’. A consequence of 
this was the anxiety rather than reassurance created by the lack of clarity: 
 
‘I think the instruction leaflet tends to be a bit vague, especially with the side effects. 
The information about side-effects can be a bit off putting. It could be off putting 
because you see the side-effects and then say ‘I’m not going to take it’ and you will 
not take the medication because of the side-effects. But you’re not guaranteed to get 
the side-effects. You might and you might not get them’ (interviewee 21). 
 
Interviewees claimed that advertising did not influence their painkiller choice with its 
role being one of reinforcement rather than conversion. However, younger 
interviewees showed a greater likelihood to recount adverts. In contrast, Kavanoor et 
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al. (1997) outlined the value of them for information acquisition, although there are 
parallels with Sinclair et al. (2000) who established that they reinforced rather than 
contributed to knowledge. Finally, interviewees who accessed relevant industry web 
sites had initiated their search due to a perceived lack of confidence with existing 
information. However, consumers found the information difficult to absorb and 
interpret, whilst there were doubts as to its impartiality. Consequently, these 
phenomena suggest that the potential for web information capitalising upon an 
increasingly consumer-driven healthcare sector, as noted by Maddox (1999), was not 
being fully harnessed. 
 
Take in Table III 
 
Product Evaluation 
Safety was considered to be a crucial evaluative dimension. However, interviewees 
with greater knowledge distinguished safe and normal use from misuse. Whilst the 
risk of side-effects increases with usage, less knowledgeable interviewees were not as 
recognisant of risk: 
 
‘What does safety mean to me? It means…it means that…I don’t understand that. 
That it doesn’t make me feel bad, sick or something? Like side effects? Or that it’s 
long term things…how dangerous do we think they are? They are just…painkillers. 
It’s not like with laser surgery for your eyes, then you have to think about the long-
term consequences, like, am I going to be blind? I mean, it’s drugs! Safe, if you ask 
me, what safe means to me, it means…that I will still be alive after taking it’ 
(interviewee 15). 
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When evaluating safety, risk minimisation existed alongside risk avoidance. Emotive 
feelings could counteract logical decision-making and rational evaluations; the spectre 
of side effects inhibited consumers from taking medication: 
 
‘The doctor…he recently explained a pill that I was advised to take, and I decided not 
to, after he read what the side effects were. I decided that I’d rather have the 
symptoms than take the pill. It could have been scary, the side effects’ (interviewee 9). 
 
Compared to safety, price lacked equivalence and significance. However, this did not 
preclude interviewees from purchasing a cheaper generic brand in preference to 
named brands. Although interviewees did not trust generic brands to be ‘as good’, 
they conceded that there were no tangible differences: 
 
‘I’d rather pay more for something I know is a quality tablet than pay less for 
something that I believe isn’t as good as something you pay more for, I know that’s 
stupid, because they’re not that special by design’ (interviewee 2). 
 
Essentially, there was recognition that subjective, rather than more objective, 
reasoning took precedence. There was a dichotomy, though, between brand-loyal as 
opposed to ingredient-loyal consumers with greater expertise and knowledge. The 
latter were more willing to countenance the substitution of their regular brand if the 
‘substitute’ had identical ingredients. 
 
To escape pain, interviewees considered the rapidity of painkiller diffusion as 
pertinent. There was a divergence of opinion in how one defined ‘fast’ with pain 
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alleviation ranging from twenty minutes to one hour. Accompanying the rapidity of 
relief, the painkiller’s perceived strength was crucial. Overall, potent drugs were 
equated with faster diffusion, but also correspondingly higher side-effects. Ultimately, 
there were finite limits to perceived strength with interviewees avoiding painkillers 
that were considered too powerful. 
 
Brand familiarity was pivotal; essentially, there were entrenched beliefs centred on 
positive associations: ‘I’ve used it before and I trust it’. Interviewees loyal to select 
brands would only direct attention to alternatives if the current brand ceased to be 
effective, which reflects earlier discussion on the focus of advertising centring 
primarily on reinforcement. If brand switching did occur, the evaluation was driven 
by the situational need for a more potent product.  
 
Take in Table IV 
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Conclusion  
Involvement and Risk 
Table V summarises the theoretical implications. These insights together with the 
managerial implications are modelled (Figure 1) in the form of a representation (Kent, 
2007) that is organised through a sequential flow diagram (Carson et al., 2001). 
Contextually, this study was situated in a market where not only are these products 
more readily available, but where this has been accompanied by an increase in self-
care information together with awareness. Overall, involvement and risk, as applied to 
OTC purchasing, intertwined and coalesced. Self-medication was indicative of a base 
level of involvement with consumers possessing an available stock. Amongst light 
and heavy users, an impending need was anticipated and there were strong 
motivations to prevent pain. Although need recognition did stimulate replenishment, 
the process of search and evaluation could occur prior to need recognition. Despite the 
greater availability and awareness of OTC medicines, the purchasing process is still 
underpinned by the inherent risk associated with this product category.  
 
Risk and unease during usage was correspondingly high. Consumers could be highly 
involved and experience a high degree of risk, and this was encapsulated by the 
situational ‘importance’. A dichotomy existed between the low levels of involvement 
during purchase, as compared to the higher distress levels during usage. Compared to 
existing involvement theory, the qualitative phenomena did not correspond to either 
low or high involvement as a distinction existed between involvement levels in 
purchase as opposed to usage. Categorising OTC painkiller purchasing as one of low 
involvement, as suggested by Rodway (1995), does not capture the full spectrum of 
emotions. 
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Information Search 
During information search, a number of challenges became apparent. Although 
consumers made recourse to a range of sources, there were perceptible feelings that 
they felt unsure as to the worth of this knowledge and this uncertainty sowed doubts. 
Compounding this, the perceived lack of clarity of packaging information generated 
anxiety rather than reassurance. Whereas Bissell et al. (2001) highlighted the 
contribution of information in reducing risk, this study has identified that there are 
perceptual barriers to surmount when gathering information. Consumer anxiety as to 
whether they had sufficient proficiency to process information limited the extent of 
search activities. Consequently, information needs to be physically and perceptually 
accessible so that it is not seen as counterproductive. Instead of encouraging proper 
usage, though, objective information could convey a message of ‘danger’ that could 
lead to consumer avoidance.  
 
Capitalising upon purchasing continuity and family history could also facilitate 
information searching as interpersonal sources were deemed to be credible and 
empathetic. The significance attached to this social element, together with its value in 
reducing risk perceptions, contrasts with Charupatanapong (1994). 
 
Product Evaluation 
When evaluating painkillers, two distinct yet interlinked phenomena emerged: the risk 
of side-effects and the relative importance of subjective as opposed to objective 
reasoning. The scope for consumers suffering from the side-effects generated by 
painkiller usage could dissuade them from using these products and, as such, these 
phenomena differ from Creyer et al. (2001) in their view that consumers saw OTCs as 
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risk-free. In instances where emotive and subjective reasoning took precedence, the 
supposed side-effects inhibited consumers from applying a painkiller. As subjective 
beliefs often assumed greater precedence over objective dimensions, neither 
Ehrenberg & Goodhart’s (1980) generic ATR model nor the more specific ‘pain, 
medication, relief’ model (Brades, 1990) fully capture this subjectivity.  
 
Difficulties in absorbing objective information exacerbated these phenomena. Where 
consumers sought to not only avoid risk, but also to minimise it, the provision of 
transparent information could potentially ameliorate these concerns and thereby 
benefit the evaluative process. In striving for this, though, there needs to be due 
acknowledgment given to the need to manage a consumer’s limits and willingness to 
assimilate new information. 
 
Take in Table V 
 
Managerial Implications 
For marketers, the theoretical insights have managerial implications (Figure 1). The 
contemporary painkiller market has been characterised by rapid growth accompanied 
with increasing sophistication. Sustaining this momentum, by capitalising on the 
sector’s continued opportunities, necessitates that future marketing efforts facilitate 
the decision-making process. In identifying the needs of, and subsequently reaching 
out to, the relevant segments, the following have been seen, respectively, as relevant: 
a broadening of consumer choice (PAGB, 2005a) together with the recognition of the 
benefits of properly communicated information (Department of Health, 2005). Within 
this rapidly evolving market, and in spite of it, there is still a degree of inherent risk 
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associated with using these products; allied to this is a base level of involvement. 
Working in tandem, a strategy that successfully harnesses this involvement also needs 
to take account of the risk that consumers experience. 
 
Uncertainty amongst consumers regarding their knowledge levels allied with the 
perceived lack of informational clarity needs to be understood. If risk amongst 
consumers is still experienced, there is a heightened need for this to be eased through 
information being made more accessible. The communication of this, though, should 
reconcile transparency with the need to ensure that consumers do not reject, or 
actively avoid, information that is perceived to be either negative or ‘dangerous’ when 
they are evaluating products. More positively, the diffusion of marketing 
communications could harness the credibility of interpersonal sources and family 
history. By harnessing and extolling these social associations, the absorption of 
information could benefit. 
 
Rather than applying these marketing tactics universally, the more disengaged 
behaviour of male consumers would suggest that these tactics would need to be 
intensified in an adapted fashion in order to reach them most effectively. 
 
Take in Figure 1 
 
Future Research  
Given the evolving nature of the OTC market, future research should adopt both a 
comparative and longitudinal dimension. Since this study was framed around female 
consumers and painkillers, a comparative approach could be structured on both intra- 
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and inter-OTC bases. At an intra-OTC level, the methodology could be replicated 
amongst male consumers, whilst another study could seek to unpack the differences 
between brands. In researching men, their differing perspectives from female 
consumers would need to be acknowledged and, as such, a replicated study could not 
seek generalisation. Additional work on an intra-OTC basis could seek to establish a 
degree of triangulation by researching the perceptions and insights of the various 
parties, such as pharmacists, that provide information. By researching their input, this 
would build upon the exploratory nature of this study. Inter-OTC comparisons could 
seek to explore these phenomena amongst other OTC medicines. Finally, longitudinal 
work that was truly immersed could explore, in depth, the degree of engagement that 
female consumers have with respect to OTC painkillers with there being the scope to 
track the extent of change over an extended time period. 
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Table I: Interviewee characteristics 
 
Geographic origin: 
Scotland – 17; England – 2; Europe – 5; Non-Europe - 1 
Educational attainment: 
Undergraduate – 7; Postgraduate – 8; School-leaving certificate - 10 
Age distribution*: 
18-29 – 11; 30-45 – 7; 46 and over – 7 
 
*Age of interviewees varied from 21 to 82 with an average age of 38. 
 
Source: authors data. 
 
Table II: Involvement and Risk in Painkiller Purchasing 
 
Phenomena Implications 
Interviewees had continual and accessible 
supply for anticipated pain 
Sudden onset of pain alleviated 
Light users as likely to have stocks as 
heavier users 
Base level of involvement amongst users 
Continual supply, but not a high degree 
of interest 
Base level of involvement does not 
equate into actual interest 
Experienced pain and application of 
medication situational 
Base level of interest evoked by transient 
conditions and immediate relevance 
Continuance and continuity of usage 
engendered reassurance 
Safety concerns were lessened  
Perception that manufacturers were 
abdicating onus of responsibility 
Uncertainty and unease amongst 
consumers  
Emotive reasoning took precedence if 
objective factors were difficult to 
interpret 
Insight and advice from multiple sources 
ameliorated this risk 
Consumers with complex medication 
patterns did not necessarily have greater 
knowledge levels 
This group had rigid perceptions of what 
variant alleviated particular symptoms; 
consumers with greater knowledge levels 
used same painkiller irrespective of 
symptom 
 
Source: analysis of interviewee responses. 
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Table III: Painkiller Purchasing and Information Search 
 
Information source and search Significance 
Internal sources – prior knowledge and 
experience 
Recounting painkiller usage evoked 
family tradition 
 
Doubts and lack of confidence as to 
whether their knowledge was meaningful 
External sources: 
 
 
 
Pharmacists 
 
 
 
Doctors 
 
 
 
 
Interpersonal sources – family/friends 
 
 
Product packaging information 
 
 
 
Adverts 
 
 
 
Pharmaceutical websites 
Information seeking initiated by regular 
brand being unavailable and/or onset of 
new symptoms 
 
Phamacists merited trust vested in them; 
pharmacists with credibility were 
consulted 
 
Doctors perceived as less trustworthy 
than pharmacists; perception that 
decisions are foisted upon consumers 
instead of process incorporating them 
 
Credibility and empathy was considered 
crucial 
 
Supplementary rather than central; lack of 
informational clarity and readability 
created anxiety 
 
Adverts did not influence painkiller 
choice; tool for reinforcement rather than 
conversion 
 
Lack of confidence with existing 
information initiated search; information 
difficult to interpret and doubts as to 
impartiality 
 
Source: analysis of interviewee responses. 
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Table IV: Painkiller Purchasing and Product Evaluation 
 
Evaluative dimension Importance 
Safety Crucially important; greater knowledge 
levels allowed safe use to be 
distinguished from misuse; simultaneous 
processes of risk minimisation together 
with risk avoidance 
Price Relatively insignificant as an evaluative 
dimension 
Speed of painkiller diffusion and effect Considered to be pertinent dimension; 
divergence of opinion as to how one 
defined ‘fast’ 
Perceived strength Crucial dimension; more potent 
painkillers equated with faster diffusion 
and higher side-effects 
Familiarity with brand Pivotal importance in shaping final 
evaluation; entrenched beliefs centring on 
positive associations 
 
Source: analysis of interviewee responses. 
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Table V: Painkiller Purchasing: theoretical implications 
 
Involvement and Risk Involvement and risk coalesced 
 
Self-medication indicative of base level 
of consumer involvement 
 
Purchasing process underpinned by 
inherent risk 
 
Low involvement during purchase, but 
higher distress levels during usage 
Information Search Doubts and uncertainty amongst 
consumers as to worth of their 
knowledge; compounded by lack of 
clarity on packaging information 
 
Perceptual barriers in gathering 
information need to be overcome; 
information needs to  be perceived as 
accessible 
 
Credibility of interpersonal sources 
creates scope to capitalise upon 
purchasing continuity and family history 
Product Evaluation Risk of side-effects could dissuade 
consumers from using painkillers 
 
Subjective beliefs and reasoning often 
assumed greater precedence over 
objective dimensions 
 
Source: based on analysis of interviewee responses. 
  
 
 
 Figure 1: Painkiller Purchasing - Theoretical Insights & Managerial Implications
Involvement (I) & Risk (R)
Coalescence of I & R                                            
↓
Self-medication indicative of base level of involvement
↓
Purchasing underpinned by inherent risk
↓
Purchase (low involvement) – usage (higher distress 
levels)
Information Search
Consumer uncertainty as to their knowledge levels
↓
Uncertainty compounded by lack of packaging clarity
↓
Consumers experience perceptual barriers during 
information gathering
Social value of interpersonal sources perceived as credible 
and empathetic
Product Evaluation
Side-effects risk could dissuade product usage
↓
Subjective and emotive beliefs often assumed precedence 
over objective dimensions
Managerial Implications
Marketers needs to harness consumer involvement
↓
Marketers need to understand and address consumers risk 
perceptions
Managerial Implications
Consumer anxiety eased with more accessible information
↓
Accessibility of information needs to be countered with 
possibility of consumer avoidance due to message being 
perceived as ‘dangerous’
Marketing communications can capitalise on positive 
associations of purchasing continuity/family history
Managerial Implications
Consumer inhibition/concern addressed through transparent 
information
↓
Information transparency needs to be balanced with 
consumer’s ability/willingness to absorb message
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